(Q43951031)

28 November 2017

Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin (English)

1 reference

28 November 2017

1 reference

Gautam A

1

1 reference

28 November 2017

Waldrep JC

2

1 reference

28 November 2017

Densmore CL

3

1 reference

28 November 2017

Koshkina N

4

1 reference

28 November 2017

Melton S

5

1 reference

28 November 2017

Roberts L

6

1 reference

28 November 2017

Gilbert B

7

1 reference

28 November 2017

Knight V

8

1 reference

28 November 2017

1 March 2002

1 reference

28 November 2017

1 reference

28 November 2017

9

1 reference

28 November 2017

5

1 reference

28 November 2017

353-357

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301662

28 November 2017

0 references

cites work

Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

Systemic gene therapy: biodistribution and long-term expression of a transgene in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

Inhibition of experimental lung metastasis by aerosol delivery of PEI-p53 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

Improved respiratory delivery of the anticancer drugs, camptothecin and paclitaxel, with 5% CO2-enriched air: pharmacokinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

Tumor suppression and therapy sensitization of localized and metastatic breast cancer by adenovirus p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

DNA topoisomerase I and II as targets for rational design of new anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

Antiangiogenic potential of camptothecin and topotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

p53 status and the efficacy of cancer therapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

7 January 2021

Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

7 January 2021

Anticancer effect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

7 January 2021

Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

7 January 2021

Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

7 January 2021

Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI Anticancer Drug Screen: multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase path

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

7 January 2021

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301662

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301662

1 reference

Dimensions Publication ID

28 November 2017

0 references

1 reference